Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Mexico Cancer Care Alliance (NMCCA) is a 501(c)(3) non-profit organization dedicated to providing New Mexico residents with access to innovative cancer treatments through a comprehensive network of clinical trials. Established in 2002, the alliance represents a unique collaboration between the University of New Mexico Comprehensive Cancer Center and major community healthcare systems, including Presbyterian Healthcare Services and Lovelace Health System. NMCCA manages the administrative, regulatory, and financial infrastructure required to conduct oncology research, allowing local physicians to offer cutting-edge investigational therapies in a community setting. By bridging the gap between national research groups and local clinics, the organization ensures that advanced cancer care is accessible to patients throughout the state. Their work focuses on improving patient outcomes and advancing the standard of care for various malignancies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Mexico Cancer Center Alliance.